Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
| 163 | 3 | THYROID//THYROID CANCER//HYPOTHYROIDISM | 61271 |
| 169 | 2 | THYROID CANCER//THYROID NODULE//THYROID | 21619 |
| 11599 | 1 | ANAPLASTIC THYROID CARCINOMA//ANAPLASTIC THYROID CANCER//LENVATINIB | 996 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | ANAPLASTIC THYROID CARCINOMA | authKW | 1226640 | 8% | 46% | 84 |
| 2 | ANAPLASTIC THYROID CANCER | authKW | 1202530 | 8% | 51% | 75 |
| 3 | LENVATINIB | authKW | 1050382 | 5% | 74% | 45 |
| 4 | E7080 | authKW | 294509 | 1% | 85% | 11 |
| 5 | ANAPLASTIC CARCINOMA | authKW | 207769 | 3% | 24% | 27 |
| 6 | ENDOCRINE NEOPLASIA HORMONAL DISORDERS | address | 206696 | 5% | 13% | 51 |
| 7 | CABOZANTINIB | authKW | 197724 | 3% | 25% | 25 |
| 8 | UNDIFFERENTIATED THYROID CANCER | authKW | 172269 | 1% | 78% | 7 |
| 9 | VANDETANIB | authKW | 145878 | 3% | 16% | 28 |
| 10 | MEDULLARY THYROID CANCER | authKW | 143949 | 3% | 13% | 34 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Oncology | 5543 | 39% | 0% | 391 |
| 2 | Endocrinology & Metabolism | 5113 | 28% | 0% | 279 |
| 3 | Surgery | 373 | 12% | 0% | 123 |
| 4 | Otorhinolaryngology | 329 | 4% | 0% | 42 |
| 5 | Pathology | 321 | 6% | 0% | 56 |
| 6 | Pharmacology & Pharmacy | 126 | 9% | 0% | 91 |
| 7 | Medicine, General & Internal | 53 | 5% | 0% | 51 |
| 8 | Medical Laboratory Technology | 33 | 1% | 0% | 12 |
| 9 | Radiology, Nuclear Medicine & Medical Imaging | 16 | 3% | 0% | 29 |
| 10 | Medicine, Research & Experimental | 7 | 2% | 0% | 23 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | ENDOCRINE NEOPLASIA HORMONAL DISORDERS | 206696 | 5% | 13% | 51 |
| 2 | NUCL MED ENDOCRINE ONCOL | 136659 | 3% | 14% | 32 |
| 3 | REFERENCE TUMEURS REFRACTAI THYROIDE | 131839 | 1% | 83% | 5 |
| 4 | CONSORTIUM CANC THYROIDIEN | 94926 | 0% | 100% | 3 |
| 5 | ISKUM | 63284 | 0% | 100% | 2 |
| 6 | SURG MED MOL PATHOL CRIT AREA | 62397 | 1% | 16% | 12 |
| 7 | ENDOCRINE MALIGNANCIES DIS ORIENTED GRP | 56953 | 0% | 60% | 3 |
| 8 | SERV MED NUCL ONCOL ENDOCRINIENNE | 56953 | 0% | 60% | 3 |
| 9 | CANC MEDUNIT 455 | 42188 | 0% | 67% | 2 |
| 10 | ANALYT PHARMACEUT SCI TECHNOL | 31642 | 0% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | THYROID | 39803 | 7% | 2% | 69 |
| 2 | ENDOCRINE-RELATED CANCER | 6600 | 2% | 1% | 19 |
| 3 | JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 4997 | 6% | 0% | 62 |
| 4 | EUROPEAN JOURNAL OF ENDOCRINOLOGY | 2369 | 2% | 0% | 20 |
| 5 | CURRENT OPINION IN ONCOLOGY | 2185 | 1% | 1% | 10 |
| 6 | CLINICAL CANCER RESEARCH | 1697 | 3% | 0% | 29 |
| 7 | MINERVA ENDOCRINOLOGICA | 1657 | 0% | 1% | 4 |
| 8 | HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 1393 | 2% | 0% | 15 |
| 9 | ENDOCRINE | 1340 | 1% | 0% | 12 |
| 10 | INTERNATIONAL JOURNAL OF ENDOCRINOLOGY | 1317 | 1% | 1% | 7 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |